Adenoviral delivery of IL-18 binding protein C ameliorates Collagen-Induced Arthritis in mice (original) (raw)

• Nakamura K et al. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989; 57: 590–595.
  CAS PubMed PubMed Central Google Scholar
• Akira S . The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12: 59–63.
  Article CAS PubMed Google Scholar
• Kohno K et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997; 158: 1541–1550.
  CAS PubMed Google Scholar
• Okamura H et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88–91.
  Article CAS PubMed Google Scholar
• Puren AJ et al. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998; 101: 711–721.
  Article CAS PubMed PubMed Central Google Scholar
• Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H . Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12: 53–72.
  Article CAS PubMed Google Scholar
• Stoll S et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998; 28: 3231–3239.
  Article CAS PubMed Google Scholar
• Stoll S et al. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 1997; 159: 298–302.
  CAS PubMed Google Scholar
• Udagawa N et al. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 1997; 185: 1005–1012.
  Article CAS PubMed PubMed Central Google Scholar
• Torigoe K et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 1997; 272: 25737–25742.
  Article CAS PubMed Google Scholar
• Born TL, Thomassen E, Bird TA, Sims JE . Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 1998; 273: 29445–29450.
  Article CAS PubMed Google Scholar
• Novick D et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999; 10: 127–136.
  Article CAS PubMed Google Scholar
• Paulukat J et al. Expression and release of IL-18 binding protein in response to IFN- gamma. J Immunol 2001; 167: 7038–7043.
  Article CAS PubMed Google Scholar
• Kim SH et al. Structural requirements of six naturally occurring isoforms of the IL- 18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000; 97: 1190–1195.
  Article CAS PubMed PubMed Central Google Scholar
• Xiang Y, Moss B . IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci USA 1999; 96: 11537–11542.
  Article CAS PubMed PubMed Central Google Scholar
• Joosten LAB et al. Association of interleukin-18 expression with enhanced levels of both interleukin-1β and Tumor Necrosis Factor α in Knee Synovial Tissue of patients with Rheumatoid Arthritis. Arthritis & Rheum 2003; 48: 339–347.
  Article CAS Google Scholar
• Bresnihan B et al. Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Ann Rheum Dis 2002; 61: 726–729.
  Article CAS PubMed PubMed Central Google Scholar
• Gracie JA et al. A proinflammatory role for IL-18 in rheumatoid arthritis [see comments]. J Clin Invest 1999; 104: 1393–1401.
  Article CAS PubMed PubMed Central Google Scholar
• Yamamura M et al. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 2001; 44: 275–285.
  Article CAS PubMed Google Scholar
• Pittoni V et al. Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis 2002; 61: 723–725.
  Article CAS PubMed PubMed Central Google Scholar
• Wei X et al. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol 2001; 166: 517–521.
  Article CAS PubMed Google Scholar
• Joosten LAB et al. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000; 165: 6553–6558.
  Article CAS PubMed Google Scholar
• Plater-Zyberk C et al. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest 2001; 108: 1825–1832.
  Article CAS PubMed PubMed Central Google Scholar
• Okamura H et al. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998; 70: 281–312.
  Article CAS PubMed Google Scholar
• Bakker AC et al. A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis. Gene Therapy 2001; 8: 1785–1793.
  Article CAS PubMed Google Scholar
• Bakker AC et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997; 40: 893–900.
  Article CAS PubMed Google Scholar
• Dinarello CA . Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000; 11: 483–486.
  CAS PubMed Google Scholar
• Dinarello CA et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998; 63: 658–664.
  Article CAS PubMed Google Scholar
• Micallef MJ et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996; 26: 1647–1651.
  Article CAS PubMed Google Scholar
• Okamura H et al. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 1998; 10: 259–264.
  Article CAS PubMed Google Scholar
• Leung BP et al. Combined effects of IL-12 and IL-18 on the induction of collagen- induced arthritis. J Immunol 2000; 164: 6495–6502.
  Article CAS PubMed Google Scholar
• Roth S et al. Anti-TNF alpha monoclonal antibodies (infliximab) and tuberculosis: apropos of 3 cases. Rev Med Interne 2002; 23: 312–316.
  Article CAS PubMed Google Scholar
• Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E . Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 2002; 31: 44–45.
  Article PubMed Google Scholar
• Sicotte NL, Voskuhl RR . Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 2001; 57: 1885–1888.
  Article CAS PubMed Google Scholar
• He TC et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509–2514.
  Article CAS PubMed PubMed Central Google Scholar
• van den Broek MF, van Den Berg WB, van de Putte LB, Severijnen AJ . Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls. Am J Pathol 1988; 133: 139–149.
  CAS PubMed PubMed Central Google Scholar
• van de Loo FAJ et al. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol 1997; 151: 177–191.
  CAS PubMed PubMed Central Google Scholar
• Drenth JP et al. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol 1995; 79: 1497–1503.
  Article CAS PubMed Google Scholar